Skip to main content

米国で取引するにはpolymarket.usへ

icon for 2026年の米国のはしか症例は？
気候と科学·パンデミック

2026年の米国のはしか症例は？

icon for 2026年の米国のはしか症例は？
気候と科学·パンデミック

2026年の米国のはしか症例は？

10月 1

1月 1, 2027

10月 1

1月 1, 2027

Polymarket

$7,894,898 Vol.

Polymarket

$7,894,898 Vol.

↑3.5千

$15,502 Vol.

100%

↑4k

$240,759 Vol.

96%

↑4.5千

$2,485 Vol.

87%

↑4.5千

$580 Vol.

84%

↑5千

$241,164 Vol.

68%

↑7.5千

$193,412 Vol.

15%

↑1万

$6,524,515 Vol.

7%

↑12.5k

$356,524 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission across 47 U.S. jurisdictions has driven 3,134 confirmed cases as of September 3, 2026, already exceeding the full-year 2025 total of 2,289 according to CDC surveillance. Primary factors include 38 active outbreaks accounting for 95% of cases, with 94% occurring among unvaccinated or unknown-status individuals and an 8% hospitalization rate, reflecting pockets of declining MMR coverage below the 95% herd-immunity threshold. Official data distinguish these verified counts from any projections, while noting ongoing weekly reporting that could shift totals before year-end resolution. Traders should monitor CDC updates for case increments and any revisions to outbreak status through December.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$7,894,898
終了日
2027/01/01
マーケット開始日
Jun 30, 2026, 2:17 PM ET

リゾルバー

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained measles transmission across 47 U.S. jurisdictions has driven 3,134 confirmed cases as of September 3, 2026, already exceeding the full-year 2025 total of 2,289 according to CDC surveillance. Primary factors include 38 active outbreaks accounting for 95% of cases, with 94% occurring among unvaccinated or unknown-status individuals and an 8% hospitalization rate, reflecting pockets of declining MMR coverage below the 95% herd-immunity threshold. Official data distinguish these verified counts from any projections, while noting ongoing weekly reporting that could shift totals before year-end resolution. Traders should monitor CDC updates for case increments and any revisions to outbreak status through December.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
音量
$7,894,898
終了日
2027/01/01
マーケット開始日
Jun 30, 2026, 2:17 PM ET

リゾルバー

0x65070BE91...

関連

icon for 2026年9月30日までに米国で少なくとも3200件以上のはしか症例が発生しますか？

2026年9月30日までに米国で少なくとも3200件以上のはしか症例が発生しますか？

99%
はい
icon for Will South Sudan have an Ebola case in 2026?

Will South Sudan have an Ebola case in 2026?

60%
icon for 2026年に新たなパンデミックが発生しますか？

2026年に新たなパンデミックが発生しますか？

6%
はい

外部リンクに注意してください。

よくある質問

「2026年の米国のはしか症例は？」はPolymarket上の12個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「↑3.5千」で100%、次いで「↑500」が100%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、100¢で取引されているシェアは、市場がその結果に100%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「2026年の米国のはしか症例は？」は$7.9 millionの総取引量を生み出しています（Dec 1, 2025のマーケット開始以来）。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「2026年の米国のはしか症例は？」で取引するには、このページに記載されている12個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「2026年の米国のはしか症例は？」の現在のフロントランナーは「↑3.5千」で100%であり、市場がこの結果に100%の確率を割り当てていることを意味します。次に近い結果は「↑500」で100%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「2026年の米国のはしか症例は？」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。